ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Washington, DC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Coronavirus Infections
Human Influenza
Communicable Diseases
Post-Acute COVID-19 Syndrome
Syndrome
Pneumonia

COVID-19 trials near Washington, DC, USA:

Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologics (COV19-APTP-B)

that suggests the potential for clinical benefit of COVID-19 patients.1. Treat Infection of Multiple Gene Mutation COVID-19...

Active, not recruiting
Covid19
Biological: COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection

Early Phase 1

Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair

North Bethesda, Maryland, United States

COVID-19 is a systemic inflammatory disease involving many organs including the lungs, vascular system liver and myocardium that le-...

Invitation-only
COVID-19
COVID Long-Haul
Other: Magnetic Resonance Imaging
Other: Ultra-High Resolution Computed Tomography (CT) Scan
Johns Hopkins University
Johns Hopkins University

Baltimore, Maryland, United States

A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or...

Active, not recruiting
COVID-19
SARS-CoV-2
Drug: VYD222 (pemivibart)
Drug: Normal saline

Phase 3

Invivyd

Silver Spring, Maryland, United States and 17 other locations

Performance of the LumiraDx SARS-CoV-2 Ag assay will be assessed by comparison to a reference method.

Active, not recruiting
Covid19
Diagnostic Test: Fingerstick
Diagnostic Test: Saliva specimen
LumiraDx

Millersville, Maryland, United States and 6 other locations

a completed primary series and bivalent booster of mRNA based COVID-19 vaccine and have =\<2500 U/mL SARS-CoV-2 S antibody concentr...

Active, not recruiting
COVID-19
Kidney Transplant
Biological: Sanofi-GSK monovalent (B.1.351) CoV2 preS dTM-AS03 COVID-19 vaccine

Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Baltimore, Maryland, United States and 5 other locations

mild to severe acute respiratory distress syndrome (ARDS) due to COVID-19 resultant from 2019-nCoV coronavirus infection, or result...

Active, not recruiting
Covid19
ARDS, Human
Biological: Longeveron Mesenchymal Stem Cells (LMSCs)
Other: Placebo

Phase 1

Longeveron

Baltimore, Maryland, United States and 2 other locations

This study is an adaptive, randomized, double blind, platform trial evaluating promising investigational products (IP) for safety and efficacy as ear...

Enrolling
SARS-CoV-2
Drug: Upamostat
Drug: Placebo (PO)

Phase 2

Henry M. Jackson Foundation for the Advancement of Military Medicine

Baltimore, Maryland, United States and 5 other locations

(SARS-CoV2) vaccine tablet VXA-CoV2-3.1 compared to a currently recommended vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID...

Enrolling
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: COMIRNATY®

Phase 2

Vaxart

Washington, District of Columbia, United States and 144 other locations

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Sub-study)
Biological: Placebo (Parent study Sentinel Safety Cohort)

Phase 2, Phase 3

AstraZeneca
AstraZeneca

Washington, District of Columbia, United States and 214 other locations

Locations recently updated

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Baltimore, Maryland, United States and 66 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems